Kathryn DiMarco
Comptroller/Controller/Auditor bij ORGANON & CO.
Vermogen: 378 820 $ op 31-03-2024
Profiel
Kathryn DiMarco is currently the Senior Vice President-Finance & Controller at Organon & Co. Prior to this, she worked as the Controller at Allergan Ltd.
(Ireland) from 2015 to 2020 and as the International Controller at Merck Sharp & Dohme Corp.
from 2014 to 2015.
She obtained her undergraduate degree from Lehigh University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ORGANON & CO.
0.01% | 31-03-2024 | 20 150 ( 0.01% ) | 378 820 $ | 31-03-2024 |
Actieve functies van Kathryn DiMarco
| Bedrijven | Functie | Begin |
|---|---|---|
| ORGANON & CO. | Comptroller/Controller/Auditor | 02-06-2021 |
Eerdere bekende functies van Kathryn DiMarco
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLERGAN PLC | Comptroller/Controller/Auditor | 01-01-2020 |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Comptroller/Controller/Auditor | 01-01-2015 |
Opleiding van Kathryn DiMarco
| Lehigh University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ORGANON & CO. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
